Glucagon Patent Expiration
Glucagon is Used for quickly raising blood sugar levels in cases of severe hypoglycemia. It was first introduced by Eli Lilly And Co
Glucagon Patents
Given below is the list of patents protecting Glucagon, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Baqsimi | US10765602 | Medication delivery systems and methods | Sep 23, 2039 | Amphastar Pharms Inc |
| Baqsimi | US10894133 | Device for dispensing a fluid product | Jan 03, 2038 | Amphastar Pharms Inc |
| Gvoke Hypopen | US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Hypopen | US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Kit | US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Pfs | US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Pfs | US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Baqsimi | US10213487 | Nasal powder formulation for treatment of hypoglycemia | Feb 16, 2036 | Amphastar Pharms Inc |
| Baqsimi | US6938798 | Fluid or powdery product dispensing device |
Jan 03, 2022
(Expired) | Amphastar Pharms Inc |
Glucagon's Family Patents
Explore Our Curated Drug Screens
Glucagon Generic API Manufacturers
Only one generic application has been filed for Glucagon.
Given below is the list of companies who have filed for Glucagon generic, along with the locations of their manufacturing plants worldwide.
1. AMPHASTAR PHARMS INC
Amphastar Pharmaceuticals Inc has filed for 1 generic for Glucagon. Given below are the details of the strengths of this generic introduced by Amphastar Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/VIAL
(reference standard) | injectable | Prescription | INJECTION | N/A | Dec 28, 2020 |